Drug Channels Archive for September, 2020

Click a link below to view the mailing archive as if it had been sent to you.

2020-09-30 07:40Drug Channels News Roundup, September 2020: FQHCs and 340B, Drug Prices, CVS Health's Zinc, Telehealth, All-Time Greatest Songs, and 10K on Twitter
2020-09-29 07:41Drug Channels - Informa Connect-CBI's 8th Annual Coupon and Copay Forum
2020-09-25 07:36Drug Channels - Mapping the Specialty Medication Journey—Digital Patient Engagement Made Easy
2020-09-23 07:40Drug Channels - Specialty Pharmacy Keeps Disrupting Buy-and-Bill—and COVID-19 Will Accelerate It
2020-09-22 07:22Drug Channels - Preorder now: The 2020-21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
2020-09-21 07:26Drug Channels - 15th Hub, SPP and eServices Summit
2020-09-18 07:34Drug Channels - Three Ways to Boost Patient Access to Orphan Drugs—With an Independent Specialty Pharmacy
2020-09-15 07:47Drug Channels - My Wall Street Journal Op-Ed about the 340B Program
2020-09-14 07:53New for 2021: The Drug Channels Quarterly Video Webinar Series
2020-09-10 07:36Drug Channels - Why Generic Medicines Are Especially Good for the U.S. Right Now
2020-09-09 07:18Drug Channels - The State of Specialty Pharmacy 2020: Market Data and Trends (video)
2020-09-08 07:36This Friday! Evolving 340B: Moving from Discounts to Rebates
2020-09-04 07:44Drug Channels - Why Do CVS And Express Scripts Rely on Secretive Private Companies to Run Their Copay Maximizer Programs? (rerun)
2020-09-03 07:37Drug Channels - Copay Maximizers Are Displacing Accumulators—But CMS Ignores How Payers Leverage Patient Support (rerun)
2020-09-02 07:37Drug Channels - Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End? (rerun)
2020-09-01 07:38Drug Channels - PBMs and Drug Spending in 2019: CVS Health and Express Scripts Outperform Prime Therapeutics (rerun)


<< Archive IndexSubscribe >>